respiratori
syncyti
viru
rsv
main
caus
viral
acut
respiratori
infect
lead
hospit
infant
young
children
worldwid
respons
hospit
bronchiol
main
complic
viral
respiratori
infect
bacteri
coinfect
respiratori
failur
synerg
viru
bacteria
wide
discuss
literatur
particularli
respiratori
virus
secondari
bacteri
pneumonia
bacteremia
rate
report
children
respiratori
ill
low
rate
case
requir
mechan
ventil
bacteri
coinfect
rate
respiratori
sampl
consist
higher
may
vari
rang
howev
preval
clinic
phenotyp
cours
bacteremia
pathogen
bacteria
set
acut
rsv
infect
infant
risk
factor
question
investig
suffici
detail
even
less
use
molecular
diagnost
aim
studi
determin
actual
rate
predict
factor
bacteremia
children
admit
hospit
due
confirm
rsv
acut
respiratori
ill
use
convent
cultur
molecular
techniqu
observ
prospect
substudi
perform
januari
januari
framework
gendr
genet
vitamin
respiratori
infect
research
wwwgendresorg
research
network
pediatr
acut
respiratori
infect
includ
spanish
tertiari
hospit
studi
previous
healthi
infant
age
two
admit
particip
hospit
gendr
network
confirm
rsv
infect
includ
patient
histori
known
immunodefici
sever
cardiac
anomali
sever
chronic
lung
diseas
neuromuscular
diseas
chromosom
abnorm
ongo
chronic
diseas
exclud
studi
complet
clinic
record
blood
sampl
nasopharyng
sampl
collect
includ
particip
sever
respiratori
episod
rank
follow
physician
criteria
mild
moder
sever
wooddown
scale
point
mild
moder
sever
newli
develop
scale
name
genvip
score
point
assess
food
toler
degre
medic
intervent
need
respiratori
distress
respiratori
frequenc
apnea
malais
fever
articl
prepar
data
tabl
studi
perform
accord
good
epidemiolog
practic
written
inform
consent
obtain
parent
legal
guardian
subject
studi
inclus
studi
approv
ethic
committe
clinic
investig
galicia
ceic
ref
patient
clinic
demograph
data
collect
use
secur
webbas
platform
rsv
statu
determin
convent
methodsrapid
test
refer
hospit
molecular
techniqu
nasopharyng
secret
rsv
assess
molecular
techniqu
nasopharyng
sampl
obtain
studi
hospit
use
either
steril
feed
tube
injector
nasopharyng
aspiratewash
steril
nylon
swab
floqswabstm
copan
diagnost
brescia
itali
without
cultur
medium
panel
virus
includ
rsv
sought
nest
polymeras
chain
reaction
pcr
method
previous
describ
et
al
peripher
blood
sampl
analysi
also
collect
patient
time
swab
edta
bd
mg
tube
becton
dickinson
franklin
lake
plymouth
uk
patient
initi
convent
bacteri
test
perform
hospit
admiss
sampl
whilst
pcr
perform
use
sampl
obtain
patient
transfer
picu
recruit
studi
pcr
result
share
clinician
due
pcr
perform
simultan
offpati
blood
sampl
pretreat
follow
blood
mix
lysozym
mgml
sigmaaldrich
st
loui
missouri
usa
lysostaphin
sigmaaldrich
st
loui
missouri
usa
vortex
briefli
incub
minut
lyse
matrix
b
bead
mp
biomed
santa
ana
california
usa
ad
mixtur
agit
use
tissuelys
ii
qiagen
hilden
germani
lysi
buffer
al
qiagen
hilden
germani
ad
sampl
centrifug
rpm
minut
pellet
lysi
bead
lyse
blood
sampl
transfer
onto
biorobot
mdx
qiagen
hilden
germani
total
nucleic
acid
extract
use
silica
membran
chemistri
elut
elut
buffer
ae
qiaamp
dna
blood
biorobot
mdx
extract
kit
qiagen
hilden
germani
nest
pcr
perform
detect
presenc
ten
differ
organ
tabl
pcr
perform
two
screen
first
round
reaction
multiplex
target
respect
first
round
reaction
perform
reaction
volum
consist
templat
nucleic
acid
extract
blood
describ
mastermix
mytaqh
biolin
reagent
london
uk
primer
ad
final
reaction
concentr
thermal
cycl
condit
first
round
reaction
minut
follow
cycl
perform
use
trio
block
thermocycl
biometra
gmbh
germani
first
round
templat
transfer
second
round
mastermix
mytaqh
mastermix
biolin
reagent
london
uk
contain
second
round
primer
final
reaction
concentr
primer
evagreen
biotium
hayward
california
usa
per
reaction
second
round
reaction
perform
lightcycl
hoffmanla
roch
basel
switzerland
use
follow
cycl
condit
minut
follow
cycl
fluoresc
acquisit
follow
melt
curv
fluoresc
acquir
melt
curv
analysi
use
detect
specif
amplif
dna
extract
pcr
amplif
bacteri
target
perform
commerci
referr
laboratori
micropatholog
ltd
mcp
mcp
accredit
clinic
patholog
accredit
uk
ltd
cpa
subsidiari
uka
provid
diagnost
patholog
servic
uk
molecular
pcr
assay
valid
cpa
standard
process
includ
primer
specif
check
inhous
method
base
analysi
public
avail
sequenc
data
ensur
observ
variat
within
speci
account
crossreact
target
identifi
sensit
pcr
ten
target
gene
copiesreact
deriv
use
combin
quantit
pcr
control
materi
amplirun
vircel
granada
spain
synthet
copi
target
amplicon
quantit
use
autom
electrophoresi
platform
multina
shimadzu
kyoto
japan
bacteremia
defin
posit
pcr
andor
blood
cultur
bacteri
superinfect
diagnosi
reli
discret
recruit
physician
accord
clinic
data
inflammatori
marker
radiolog
find
andor
appropri
cultur
pcr
done
children
discharg
result
share
clinician
pcr
perform
simultan
offpati
respiratori
support
consid
either
invas
mechan
ventil
noninvas
ventil
cpap
bipap
sever
respiratori
episod
rank
physician
criteria
mild
moder
sever
respiratori
distress
rate
worst
moment
ill
spanish
nation
immun
program
includ
hib
vaccin
pneumococc
conjug
vaccin
howev
averag
vaccin
coverag
pneumococc
conjuag
vaccin
estim
privat
market
perform
analys
use
r
softwar
version
http
wwwrprojectorg
gener
data
present
percentag
mean
confid
interv
differ
statist
test
use
assess
associ
variabl
fisher
exact
test
discret
variabl
wilcoxon
test
continu
variabl
elig
patient
rsv
posit
data
fig
n
month
age
major
patient
boy
children
correctli
vaccin
accord
recommend
nation
immun
schedul
diagnosi
discharg
predominantli
bronchiol
n
pneumonia
n
n
rsv
posit
patient
suspect
bacteri
superinfect
accord
refer
physician
molecular
assess
reveal
bacteri
presenc
blood
seven
patient
tabl
differ
found
neg
posit
pcr
term
sex
distribut
age
famili
histori
vaccin
rate
diagnosi
suspicion
bacteri
superinfect
signific
differ
term
ill
sever
children
posit
bacteri
pcr
neg
result
picu
admiss
vs
pvalu
respiratori
support
necess
vs
pvalu
patient
confirm
bacteremia
sever
respiratori
affect
bacteria
identifi
blood
tabl
wooddown
score
genvip
scale
indic
wors
valu
blood
pcr
posit
patient
mean
point
point
respect
blood
pcr
neg
patient
mean
point
point
pvalu
hospit
longer
children
pcrconfirm
bacteremia
mean
vs
day
pvalu
fig
pathogen
found
h
influenza
n
pneumonia
n
simltan
n
cycl
threshold
except
pneumonia
coinfect
case
cycl
threshold
one
case
bacteria
also
identifi
convent
cultur
nasopharyng
sampl
one
viru
detect
patient
molecular
techniqu
bacteri
pcr
posit
patient
viral
coinfect
observ
subject
tabl
patient
viral
coinfect
neg
pcr
identifi
n
patient
two
viru
n
three
viru
statist
differ
observ
term
viral
coinfect
posit
neg
bacteri
pcr
pvalu
antibiot
administr
patient
suspect
bacteri
superinfect
record
n
rsvinfect
patient
n
patient
bacteri
superinfect
confirm
convent
blood
cultur
patient
confirm
bacteremia
pcr
n
patient
treat
antibiot
due
suspect
bacteri
superinfect
patient
wide
spectrum
antibiot
use
correl
patient
suspect
superinfect
andor
prescrib
antibiot
refer
physician
posit
blood
pcr
result
cohen
kappa
coeffici
bacteri
superinfectionpcr
total
patient
present
fever
includ
children
lowgrad
fever
fever
frequenc
children
bacteremia
confirm
pcr
similar
rest
cohort
pvalu
one
everi
ten
previous
healthi
children
hospit
due
rsv
bacteremia
patient
experienc
sever
diseas
convers
half
ot
remain
rsv
patient
includ
receiv
empir
antibiot
therapi
despit
bacteremia
workup
result
neg
preval
bacteremia
children
rsv
infect
report
literatur
low
rang
studi
found
rate
concurr
bacteremia
ten
time
higher
studi
cite
convent
cultur
perform
wherea
molecular
method
appli
seri
rsv
link
season
increas
pneumonia
diseas
well
virus
influenza
underli
mechan
viral
bacteri
synerg
complex
remain
unclear
immun
program
conjug
vaccin
invas
h
influenza
serotyp
b
streptococcu
pneumonia
chang
frequenc
bacteremia
febril
infant
seri
pcr
posit
patient
vaccin
pneumococc
diseas
compar
pcr
neg
one
receiv
vaccin
anim
studi
found
import
mechan
viralbacteri
synergi
bovin
rsv
histophilu
somni
bacteri
pathogen
could
indic
rsv
hinfluenza
infect
pattern
human
patient
diagnosi
bacteri
superinfect
often
made
clinic
ground
alway
confirm
microbiolog
antibiot
administ
rsvinfect
children
unless
complic
secondari
bacteri
ill
occur
seri
blood
cultur
carri
systemat
bacteri
superinfect
suspect
refer
physician
blood
cultur
consid
gold
standard
bacteria
detect
low
sensit
bacteria
difficult
cultur
blood
perform
recruit
patient
clinic
relev
posit
result
clear
detect
circul
dna
blood
pcr
limit
essenti
extrapol
alway
result
obtain
clinic
ground
see
pcr
result
clinic
phenotyp
consist
quantit
pcr
cycl
threshold
valu
invers
correl
bacteria
load
could
indic
avoid
fals
posit
result
cohort
cycl
threshold
seven
posit
sampl
could
establish
maximum
cutoff
level
seri
physician
suspect
bacteri
superinfect
half
case
proport
similar
thibeault
et
al
studi
even
though
blood
cultur
obtain
mani
patient
n
yield
posit
result
furthermor
fail
find
correl
pcrconfirm
bacteremia
clinic
suspicion
bacteri
superinfect
cohen
kappa
coeffici
therefor
agreement
studi
found
children
uncompl
bacteri
rsv
infect
often
overtr
empir
antibiot
empir
antibiot
treatment
often
prescrib
practic
children
hospit
due
confirm
viral
ari
base
fever
presenc
persist
case
bronchiol
associ
fever
seri
fever
rate
rang
previous
describ
children
hospit
rsv
howev
risk
bacteremia
low
febril
children
bronchiol
corrobor
seri
fever
predictor
bacteremia
pvalu
randolph
et
al
studi
risk
bacteri
infect
children
infect
rsv
admit
picu
use
blood
cultur
found
rate
bacteremia
studi
rate
bacteremia
found
pcr
children
requir
picu
admiss
higher
probabl
due
higher
sensit
molecular
techniqu
bacterem
patient
sever
cours
accord
picu
admiss
rate
respiratori
support
necess
clinic
scale
length
hospit
bloomfield
et
al
suggest
empir
antibiot
consid
child
admit
picu
rsv
infect
requir
ventil
seri
half
patient
admit
picu
requir
ventilatori
support
bacteremia
reveal
pcr
mean
antibiot
prescript
might
superflu
case
howev
pcr
perform
blood
mean
would
exclud
system
bacteri
infect
form
bacteri
superinfect
hand
due
limit
number
bacterem
subject
studi
studi
need
make
robust
conclus
regard
overus
underus
antibiot
therapi
conclus
data
show
concurr
bacteremia
frequent
infant
hospit
rsv
respiratori
infect
even
presenc
fever
despit
use
molecular
techniqu
diagnosi
howev
bacteremia
may
actual
occur
suspect
sever
case
although
sampl
size
allow
us
find
reliabl
predict
clinic
pattern
antibiot
frequent
overus
set
rsv
infect
judici
approach
prescript
warrant
